Jun 08, 2021 / 12:00PM GMT
Operator
Hello, and welcome to the PDS Biotechnology Post ASCO Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Deanne Randolph, Vice President, Commercial Development. Please go ahead.
Deanne Randolph - PDS Biotechnology Corporation - VP of Commercial Development & Head of IR
Good morning, and welcome to PDS Biotechnology's Post ASCO webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and Dr. Seth Van Voorhees, Chief Financial Officer.
Earlier this morning, PDS Biotech issued a press release summarizing the data presented yesterday afternoon at the American Society of Clinical Oncology Annual Meeting. The company's press release is available on PDS Biotech's website at pdsbiotech.com, and a recording of this webcast will be posted to the website later today and will be archived there for future reference.
Before we begin, I would like to caution listeners that comments made by
PDS Biotechnology Post-ASCO Conference Call - Corporate Analyst Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot